Covid-19 Impact on Global Hemato Oncology Testing Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 08-May-2020
No. of pages: 96
Inquire Before Buying

This report focuses on the global Hemato Oncology Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemato Oncology Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- F. Hoffmann-La Roche

- Abbott Laboratories

- Thermo Fisher Scientific

- QIAGEN N.V.

- Bio-Rad Laboratories

- Illumina

- MolecularMD

- Invivoscribe

- Asuragen

- Adaptive Biotechnologies

- ArcherDx

- ARUP Laboratories

Market segment by Type, the product can be split into

- Leukemia Testing

- Acute Myeloid Testing

- Multiple Myeloma Testing

- Other

Market segment by Application, split into

- Clinical Laboratories

- Hospitals

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Hemato Oncology Testing status, future forecast, growth opportunity, key market and key players.

- To present the Hemato Oncology Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hemato Oncology Testing are as follows:

- History Year: 2015-2019

- Base Year: 2019

- Estimated Year: 2020

- Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Covid-19 Impact on Global Hemato Oncology Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemato Oncology Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Leukemia Testing
1.4.3 Acute Myeloid Testing
1.4.4 Multiple Myeloma Testing
1.4.5 Other
1.5 Market by Application
1.5.1 Global Hemato Oncology Testing Market Share by Application: 2020 VS 2026
1.5.2 Clinical Laboratories
1.5.3 Hospitals
1.6 Coronavirus Disease 2019 (Covid-19): Hemato Oncology Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemato Oncology Testing Industry
1.6.1.1 Hemato Oncology Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemato Oncology Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemato Oncology Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Hemato Oncology Testing Market Perspective (2015-2026)
2.2 Hemato Oncology Testing Growth Trends by Regions
2.2.1 Hemato Oncology Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemato Oncology Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hemato Oncology Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Hemato Oncology Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Hemato Oncology Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hemato Oncology Testing Players by Market Size
3.1.1 Global Top Hemato Oncology Testing Players by Revenue (2015-2020)
3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemato Oncology Testing Market Concentration Ratio
3.2.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2019
3.3 Hemato Oncology Testing Key Players Head office and Area Served
3.4 Key Players Hemato Oncology Testing Product Solution and Service
3.5 Date of Enter into Hemato Oncology Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Hemato Oncology Testing Historic Market Size by Type (2015-2020)
4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2021-2026)
5 Hemato Oncology Testing Breakdown Data by Application (2015-2026)
5.1 Global Hemato Oncology Testing Market Size by Application (2015-2020)
5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hemato Oncology Testing Market Size (2015-2020)
6.2 Hemato Oncology Testing Key Players in North America (2019-2020)
6.3 North America Hemato Oncology Testing Market Size by Type (2015-2020)
6.4 North America Hemato Oncology Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hemato Oncology Testing Market Size (2015-2020)
7.2 Hemato Oncology Testing Key Players in Europe (2019-2020)
7.3 Europe Hemato Oncology Testing Market Size by Type (2015-2020)
7.4 Europe Hemato Oncology Testing Market Size by Application (2015-2020)
8 China
8.1 China Hemato Oncology Testing Market Size (2015-2020)
8.2 Hemato Oncology Testing Key Players in China (2019-2020)
8.3 China Hemato Oncology Testing Market Size by Type (2015-2020)
8.4 China Hemato Oncology Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hemato Oncology Testing Market Size (2015-2020)
9.2 Hemato Oncology Testing Key Players in Japan (2019-2020)
9.3 Japan Hemato Oncology Testing Market Size by Type (2015-2020)
9.4 Japan Hemato Oncology Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hemato Oncology Testing Market Size (2015-2020)
10.2 Hemato Oncology Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemato Oncology Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Hemato Oncology Testing Market Size by Application (2015-2020)
11 India
11.1 India Hemato Oncology Testing Market Size (2015-2020)
11.2 Hemato Oncology Testing Key Players in India (2019-2020)
11.3 India Hemato Oncology Testing Market Size by Type (2015-2020)
11.4 India Hemato Oncology Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hemato Oncology Testing Market Size (2015-2020)
12.2 Hemato Oncology Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemato Oncology Testing Market Size by Type (2015-2020)
12.4 Central & South America Hemato Oncology Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Details
13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche Hemato Oncology Testing Introduction
13.1.4 F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview and Its Total Revenue
13.2.3 Abbott Laboratories Hemato Oncology Testing Introduction
13.2.4 Abbott Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.3.3 Thermo Fisher Scientific Hemato Oncology Testing Introduction
13.3.4 Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 QIAGEN N.V.
13.4.1 QIAGEN N.V. Company Details
13.4.2 QIAGEN N.V. Business Overview and Its Total Revenue
13.4.3 QIAGEN N.V. Hemato Oncology Testing Introduction
13.4.4 QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2015-2020)
13.4.5 QIAGEN N.V. Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.5.3 Bio-Rad Laboratories Hemato Oncology Testing Introduction
13.5.4 Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
13.6 Illumina
13.6.1 Illumina Company Details
13.6.2 Illumina Business Overview and Its Total Revenue
13.6.3 Illumina Hemato Oncology Testing Introduction
13.6.4 Illumina Revenue in Hemato Oncology Testing Business (2015-2020)
13.6.5 Illumina Recent Development
13.7 MolecularMD
13.7.1 MolecularMD Company Details
13.7.2 MolecularMD Business Overview and Its Total Revenue
13.7.3 MolecularMD Hemato Oncology Testing Introduction
13.7.4 MolecularMD Revenue in Hemato Oncology Testing Business (2015-2020)
13.7.5 MolecularMD Recent Development
13.8 Invivoscribe
13.8.1 Invivoscribe Company Details
13.8.2 Invivoscribe Business Overview and Its Total Revenue
13.8.3 Invivoscribe Hemato Oncology Testing Introduction
13.8.4 Invivoscribe Revenue in Hemato Oncology Testing Business (2015-2020)
13.8.5 Invivoscribe Recent Development
13.9 Asuragen
13.9.1 Asuragen Company Details
13.9.2 Asuragen Business Overview and Its Total Revenue
13.9.3 Asuragen Hemato Oncology Testing Introduction
13.9.4 Asuragen Revenue in Hemato Oncology Testing Business (2015-2020)
13.9.5 Asuragen Recent Development
13.10 Adaptive Biotechnologies
13.10.1 Adaptive Biotechnologies Company Details
13.10.2 Adaptive Biotechnologies Business Overview and Its Total Revenue
13.10.3 Adaptive Biotechnologies Hemato Oncology Testing Introduction
13.10.4 Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2015-2020)
13.10.5 Adaptive Biotechnologies Recent Development
13.11 ArcherDx
10.11.1 ArcherDx Company Details
10.11.2 ArcherDx Business Overview and Its Total Revenue
10.11.3 ArcherDx Hemato Oncology Testing Introduction
10.11.4 ArcherDx Revenue in Hemato Oncology Testing Business (2015-2020)
10.11.5 ArcherDx Recent Development
13.12 ARUP Laboratories
10.12.1 ARUP Laboratories Company Details
10.12.2 ARUP Laboratories Business Overview and Its Total Revenue
10.12.3 ARUP Laboratories Hemato Oncology Testing Introduction
10.12.4 ARUP Laboratories Revenue in Hemato Oncology Testing Business (2015-2020)
10.12.5 ARUP Laboratories Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Hemato Oncology Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Hemato Oncology Testing Revenue
Table 3. Ranking of Global Top Hemato Oncology Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemato Oncology Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Leukemia Testing
Table 6. Key Players of Acute Myeloid Testing
Table 7. Key Players of Multiple Myeloma Testing
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Hemato Oncology Testing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemato Oncology Testing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemato Oncology Testing Players to Combat Covid-19 Impact
Table 14. Global Hemato Oncology Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Hemato Oncology Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Hemato Oncology Testing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Hemato Oncology Testing Market Share by Regions (2015-2020)
Table 18. Global Hemato Oncology Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Hemato Oncology Testing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Hemato Oncology Testing Market Growth Strategy
Table 24. Main Points Interviewed from Key Hemato Oncology Testing Players
Table 25. Global Hemato Oncology Testing Revenue by Players (2015-2020) (Million US$)
Table 26. Global Hemato Oncology Testing Market Share by Players (2015-2020)
Table 27. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2019)
Table 28. Global Hemato Oncology Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Hemato Oncology Testing Product Solution and Service
Table 31. Date of Enter into Hemato Oncology Testing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 34. Global Hemato Oncology Testing Market Size Share by Type (2015-2020)
Table 35. Global Hemato Oncology Testing Revenue Market Share by Type (2021-2026)
Table 36. Global Hemato Oncology Testing Market Size Share by Application (2015-2020)
Table 37. Global Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 38. Global Hemato Oncology Testing Market Size Share by Application (2021-2026)
Table 39. North America Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 41. North America Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 42. North America Hemato Oncology Testing Market Share by Type (2015-2020)
Table 43. North America Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 44. North America Hemato Oncology Testing Market Share by Application (2015-2020)
Table 45. Europe Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 47. Europe Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Hemato Oncology Testing Market Share by Type (2015-2020)
Table 49. Europe Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Hemato Oncology Testing Market Share by Application (2015-2020)
Table 51. China Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 52. China Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 53. China Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 54. China Hemato Oncology Testing Market Share by Type (2015-2020)
Table 55. China Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 56. China Hemato Oncology Testing Market Share by Application (2015-2020)
Table 57. Japan Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 59. Japan Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Hemato Oncology Testing Market Share by Type (2015-2020)
Table 61. Japan Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Hemato Oncology Testing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 65. Southeast Asia Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Hemato Oncology Testing Market Share by Type (2015-2020)
Table 67. Southeast Asia Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Hemato Oncology Testing Market Share by Application (2015-2020)
Table 69. India Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 70. India Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 71. India Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 72. India Hemato Oncology Testing Market Share by Type (2015-2020)
Table 73. India Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 74. India Hemato Oncology Testing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Hemato Oncology Testing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Hemato Oncology Testing Market Share (2019-2020)
Table 77. Central & South America Hemato Oncology Testing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Hemato Oncology Testing Market Share by Type (2015-2020)
Table 79. Central & South America Hemato Oncology Testing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Hemato Oncology Testing Market Share by Application (2015-2020)
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Product
Table 84. F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Abbott Laboratories Company Details
Table 87. Abbott Laboratories Business Overview
Table 88. Abbott Laboratories Product
Table 89. Abbott Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 90. Abbott Laboratories Recent Development
Table 91. Thermo Fisher Scientific Company Details
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Product
Table 94. Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 95. Thermo Fisher Scientific Recent Development
Table 96. QIAGEN N.V. Company Details
Table 97. QIAGEN N.V. Business Overview
Table 98. QIAGEN N.V. Product
Table 99. QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 100. QIAGEN N.V. Recent Development
Table 101. Bio-Rad Laboratories Company Details
Table 102. Bio-Rad Laboratories Business Overview
Table 103. Bio-Rad Laboratories Product
Table 104. Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 105. Bio-Rad Laboratories Recent Development
Table 106. Illumina Company Details
Table 107. Illumina Business Overview
Table 108. Illumina Product
Table 109. Illumina Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 110. Illumina Recent Development
Table 111. MolecularMD Company Details
Table 112. MolecularMD Business Overview
Table 113. MolecularMD Product
Table 114. MolecularMD Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 115. MolecularMD Recent Development
Table 116. Invivoscribe Business Overview
Table 117. Invivoscribe Product
Table 118. Invivoscribe Company Details
Table 119. Invivoscribe Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 120. Invivoscribe Recent Development
Table 121. Asuragen Company Details
Table 122. Asuragen Business Overview
Table 123. Asuragen Product
Table 124. Asuragen Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 125. Asuragen Recent Development
Table 126. Adaptive Biotechnologies Company Details
Table 127. Adaptive Biotechnologies Business Overview
Table 128. Adaptive Biotechnologies Product
Table 129. Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 130. Adaptive Biotechnologies Recent Development
Table 131. ArcherDx Company Details
Table 132. ArcherDx Business Overview
Table 133. ArcherDx Product
Table 134. ArcherDx Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 135. ArcherDx Recent Development
Table 136. ARUP Laboratories Company Details
Table 137. ARUP Laboratories Business Overview
Table 138. ARUP Laboratories Product
Table 139. ARUP Laboratories Revenue in Hemato Oncology Testing Business (2015-2020) (Million US$)
Table 140. ARUP Laboratories Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemato Oncology Testing Market Share by Type: 2020 VS 2026
Figure 2. Leukemia Testing Features
Figure 3. Acute Myeloid Testing Features
Figure 4. Multiple Myeloma Testing Features
Figure 5. Other Features
Figure 6. Global Hemato Oncology Testing Market Share by Application: 2020 VS 2026
Figure 7. Clinical Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Hemato Oncology Testing Report Years Considered
Figure 10. Global Hemato Oncology Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hemato Oncology Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Hemato Oncology Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hemato Oncology Testing Market Share by Players in 2019
Figure 15. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2019
Figure 17. North America Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hemato Oncology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. F. Hoffmann-La Roche Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 26. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 28. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Thermo Fisher Scientific Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 30. QIAGEN N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. QIAGEN N.V. Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 32. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bio-Rad Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 34. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Illumina Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 36. MolecularMD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. MolecularMD Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 38. Invivoscribe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Invivoscribe Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 40. Asuragen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Asuragen Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 42. Adaptive Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Adaptive Biotechnologies Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 44. ArcherDx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. ArcherDx Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 46. ARUP Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ARUP Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs